Effects of meropenem plus ulinastatin on inflammatory response and complications in patients with severe septic shock

乌司他丁 医学 感染性休克 全身炎症反应综合征 麻醉 败血症 血流动力学 平均动脉压 心率 外科 内科学 血压 临床试验 队列 前瞻性队列研究 炎症反应 白细胞 血流动力学反应 队列研究 随机对照试验 单中心 B组 心脏指数 休克(循环) 胃肠病学 回顾性队列研究 传统PCI 护理标准
作者
Di Wu,Wei Min NI,Xinying Zhang,Xiaodong Liu
出处
期刊:Frontiers in Medicine [Frontiers Media]
卷期号:13: 1860367-1860367
标识
DOI:10.3389/fmed.2026.1860367
摘要

Aim To evaluate whether receipt of ulinastatin in addition to meropenem-based standard care was associated with inflammatory, coagulation, perfusion, and clinical outcomes in patients with severe septic shock. Methods This single-center retrospective, non-randomized comparative cohort study included 106 consecutive patients with severe septic shock treated between January 2023 and November 2025. Patients were classified according to treatment received in routine clinical practice: meropenem-based standard care plus ulinastatin (observation group, n = 53) or meropenem-based standard care alone (control group, n = 53). Twenty-eight-day all-cause mortality was presented as the principal objective patient-centered clinical outcome, whereas the total effective rate was reported only as an exploratory secondary outcome. Results The overall response rate in the observation group presented higher at 90.6% (48/53) versus 73.6% (39/53) in the control group ( p < 0.05). Post-treatment, the observation group presented lower levels of CRP, PCT, IL-6, IL-8, along with TNF-α ( p < 0.05). For coagulation, post-treatment Fib levels were lower in the observation group compared to the control group, while PT and APTT were markedly shortened in the observation group ( p < 0.05). Hemodynamic parameters—heart rate (HR), mean arterial pressure (MAP), along with cardiac index (CI)—showed greater improvement in the observation group ( p < 0.05). Regarding immunity, the observation group presented higher CD4 + T cell counts and CD4 + /CD8 + ratios, as well as significantly lower CD8 + T cell counts versus the control group ( p < 0.05). The 6-h and 24-h lactate clearance rates were significantly higher in the observation group ( p < 0.001 for both). ICU stay and mechanical ventilation duration were shorter in the observation group ( p < 0.001 for both). The complication rate was 9.4% (5/53) in the observation group, which was lower than the 24.5% (13/53) seen in the control group ( p < 0.05). Conclusion In this single-center retrospective cohort, receipt of ulinastatin in addition to meropenem-based standard care was associated with more favorable inflammatory, coagulation, lactate-clearance, hemodynamic, immune, and resource-use outcomes. Because treatment was not randomized and residual confounding cannot be excluded, these findings should not be interpreted as proof of causality or synergy.

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
英姑的应助被科研通管家采纳,获得10
刚刚
CarryLJR的应助被科研通管家采纳,获得10
1秒前
慕青的应助被科研通管家采纳,获得10
1秒前
烟花的应助被科研通管家采纳,获得10
1秒前
cndoupu的应助被科研通管家采纳,获得10
1秒前
Hello的应助被科研通管家采纳,获得10
1秒前
1秒前
1秒前
1秒前
2秒前
2秒前
3秒前
初雪完成签到,获得积分0
4秒前
4秒前
初景的应助被mont采纳,获得20
4秒前
初景的应助被mont采纳,获得20
4秒前
秋风的应助被mont采纳,获得10
4秒前
科研通AI6.3的应助被mont采纳,获得10
4秒前
科研通AI6.3的应助被mont采纳,获得10
5秒前
shenkekeshen的应助被mont采纳,获得10
5秒前
5秒前
6秒前
6秒前
7秒前
7秒前
温柔迎波完成签到,获得积分10
7秒前
8秒前
山竹里发布了新的文献求助10
8秒前
8秒前
悠然南山发布了新的文献求助10
9秒前
10秒前
10秒前
细水长流发布了新的文献求助10
11秒前
11秒前
GMH完成签到 ,获得积分10
11秒前
wei完成签到,获得积分10
11秒前
乐乐的应助被mont采纳,获得20
11秒前
aujsdhab发布了新的文献求助10
11秒前
科研通AI6.2的应助被mont采纳,获得10
11秒前
Pdnnnnn发布了新的文献求助10
12秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
The World Atlas of Wine 9th edition 1000
Sex, Aging, and Death in a Medieval Medical Compendium: Trinity College Cambridge MS R.14.52, Its Texts, Language, and Scribe 500
高分子基功能界面水蒸发材料与应用研究 500
外场增强的水汽发电研究 500
基于结构调控的功能化水诱导发电材料与器件研究 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8189472
求助须知:如何正确求助?哪些是违规求助? 9576774
关于积分的说明 21849709
捐赠科研通 7787422
什么是DOI,文献DOI怎么找? 3435600
关于科研通互助平台的介绍 2559782
邀请新用户注册赠送积分活动 2482552